Specialties

Baseline hemoglobin A1C may be inversely proportional to the risk of statin-induced new-onset diabetes. 

Seventeen common biomarkers were differentially expressed in patients with Alzheimer’s Disease or type 2 diabetes when compared with healthy controls. 

According to research presented by Dr. George Bakris of the University of Chicago, treatment with finerenone resulted in a lower risk of the progression of chronic kidney disease and cardiovascular events. 

Insulin-dependent diabetes mellitus may be linked to male reproductive dysfunction. 

Patients who suffer from mild to extreme mental health stress are less likely to participate in self-care behavior for diabetes.

Diabetes or prediabetes may put a patient at higher risk of developing cardiovascular diseases.

The impact of impaired healing in those with diabetes mellitus (DM) contributes to their higher risk of developing periodontitis, leading to tooth loss (TL).  

All male patients with low testosterone levels are at a higher risk for cardiovascular disease, especially those with type 2 diabetes mellitus.  

Dapagliflozin (Farxiga®) has been granted U.S. Food and Drug Administration (FDA)  Breakthrough Therapy Designation (BTD) for patients with chronic kidney disease (CKD), whether or not they have type 2 diabetes. 

Should current guidelines lower the blood pressure treatment threshold for increased prevention of CVD?